Showing results (121-130 of 1,553) with videos related to

Sort By:
Pageof 156
Drugs|October 18, 2013
Preventing postoperative recurrence in Crohn's disease: what does the future hold?Lucine Vuitton, Stéphane Koch, Laurent Peyrin-Biroulet
Journal of Clinical Medicine|June 19, 2024
Benefits of Biosimilars in the Management of Patients with Inflammatory Bowel Disease: An International SurveyFerdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Gastroenterology & Hepatology|February 26, 2024
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Sailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Gut|September 7, 2017
Early intervention in Crohn's disease: towards disease modification trialsSilvio Danese, Gionata Fiorino, Laurent Peyrin-Biroulet
Current Drug Targets|May 1, 2013
Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatmentLucine Vuitton, Stéphane Koch, Laurent Peyrin-Biroulet
Autoimmunity Reviews|December 21, 2018
Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapiesLaurent Peyrin-Biroulet, Stephen Demarest, Ajay Nirula
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2012
Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studiesTine Jess, Christine Rungoe, Laurent Peyrin-Biroulet
Expert Review of Clinical Immunology|November 4, 2014
Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?Anthony Lopez, Laurent Beaugerie, Laurent Peyrin-Biroulet
Journal of Crohn'S & Colitis|October 30, 2024
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced TherapiesBénédicte Caron, Sailish Honap, Laurent Peyrin-Biroulet
Pageof 156